Suppr超能文献

活化B细胞样弥漫性大B细胞淋巴瘤中的异常免疫球蛋白类别转换重组和转换易位

Aberrant immunoglobulin class switch recombination and switch translocations in activated B cell-like diffuse large B cell lymphoma.

作者信息

Lenz Georg, Nagel Inga, Siebert Reiner, Roschke Anna V, Sanger Warren, Wright George W, Dave Sandeep S, Tan Bruce, Zhao Hong, Rosenwald Andreas, Muller-Hermelink Hans Konrad, Gascoyne Randy D, Campo Elias, Jaffe Elaine S, Smeland Erlend B, Fisher Richard I, Kuehl W Michael, Chan Wing C, Staudt Louis M

机构信息

Metabolism Branch, Division of Cancer Treatment and Diagnosis, National Cancer Institute (NCI), National Institutes of Health (NIH), Bethesda, MD 20892, USA.

出版信息

J Exp Med. 2007 Mar 19;204(3):633-43. doi: 10.1084/jem.20062041. Epub 2007 Mar 12.

Abstract

To elucidate the mechanisms underlying chromosomal translocations in diffuse large B cell lymphoma (DLBCL), we investigated the nature and extent of immunoglobulin class switch recombination (CSR) in these tumors. We used Southern blotting to detect legitimate and illegitimate CSR events in tumor samples of the activated B cell-like (ABC), germinal center B cell-like (GCB), and primary mediastinal B cell lymphoma (PMBL) subgroups of DLBCL. The frequency of legitimate CSR was lower in ABC DLBCL than in GCB DLBCL and PMBL. In contrast, ABC DLBCL had a higher frequency of internal deletions within the switch mu (Smu) region compared with GCB DLBCL and PMBL. ABC DLBCLs also had frequent deletions within Sgamma and other illegitimate switch recombinations. Sequence analysis revealed ongoing Smu deletions within ABC DLBCL tumor clones, which were accompanied by ongoing duplications and activation-induced cytidine deaminase-dependent somatic mutations. Unexpectedly, short fragments derived from multiple chromosomes were interspersed within Smu in one case. These findings suggest that ABC DLBCLs have abnormalities in the regulation of CSR that could predispose to chromosomal translocations. Accordingly, aberrant switch recombination was responsible for translocations in ABC DLBCLs involving BCL6, MYC, and a novel translocation partner, SPIB.

摘要

为了阐明弥漫性大B细胞淋巴瘤(DLBCL)中染色体易位的潜在机制,我们研究了这些肿瘤中免疫球蛋白类别转换重组(CSR)的性质和程度。我们使用Southern印迹法检测DLBCL的活化B细胞样(ABC)、生发中心B细胞样(GCB)和原发性纵隔B细胞淋巴瘤(PMBL)亚组肿瘤样本中的合法和非法CSR事件。ABC DLBCL中合法CSR的频率低于GCB DLBCL和PMBL。相比之下,与GCB DLBCL和PMBL相比,ABC DLBCL在转换μ(Smu)区域内的内部缺失频率更高。ABC DLBCL在Sγ内也有频繁的缺失和其他非法转换重组。序列分析显示ABC DLBCL肿瘤克隆内存在持续的Smu缺失,同时伴有持续的重复和活化诱导的胞苷脱氨酶依赖性体细胞突变。出乎意料的是,在一个病例中,来自多条染色体的短片段散布在Smu内。这些发现表明ABC DLBCL在CSR调节方面存在异常,这可能易导致染色体易位。因此,异常的转换重组是ABC DLBCL中涉及BCL6、MYC和一个新的易位伙伴SPIB的易位的原因。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1f6a/2137913/9e4dfb521bc3/jem2040633f01.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验